Zentek Ltd. (ZTEK)
NASDAQ: ZTEK · Real-Time Price · USD
0.6700
0.00 (0.00%)
At close: Aug 29, 2025, 4:00 PM
0.6800
+0.0100 (1.49%)
After-hours: Aug 29, 2025, 7:45 PM EDT
Zentek Revenue
Zentek had revenue of 57.80K CAD in the quarter ending June 30, 2025, with 952.96% growth. This brings the company's revenue in the last twelve months to 924.80K, up 2,519.47% year-over-year. In the fiscal year ending March 31, 2025, Zentek had annual revenue of 872.50K with 2,826.26% growth.
Revenue (ttm)
924.80K CAD
Revenue Growth
+2,519.47%
P/S Ratio
102.29
Revenue / Employee
54,400 CAD
Employees
17
Market Cap
69.36M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 872.50K | 842.68K | 2,826.26% |
Mar 31, 2024 | 29.82K | -43.04K | -59.07% |
Mar 31, 2023 | 72.86K | -274.33K | -79.02% |
Mar 31, 2022 | 347.18K | 344.83K | 14,642.38% |
Mar 31, 2021 | 2.36K | - | - |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
ZTEK News
- 5 days ago - Zentek Ltd. Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency - Newsfile Corp
- 6 days ago - Top 3 Health Care Stocks You'll Regret Missing This Quarter - Benzinga
- 7 weeks ago - Zentek Announces Management Transition - Accesswire
- 2 months ago - Zentek Provides Regulatory Update on ZenGUARD(TM) Enhanced Air Filters - Accesswire
- 2 months ago - Zentek Announces Test Results Validating ZenGUARD(TM) Enhanced Air Filters as a High-Performance Solution for ASHRAE Standard 241 Compliance - Accesswire
- 3 months ago - Zentek Announces Agreement with RSK Environment Limited to Expand International Reach of ZenGUARD(TM) Enhanced Air Filters - Accesswire
- 3 months ago - Zentek Announces Completion of Sale of Corporate Court Office - Accesswire
- 4 months ago - Zentek Announces Purchase Order from Dexterra Group Inc. for ZenGUARD(TM) Enhanced Air Filters - Accesswire